|
1
|
Butler SL, Dong H, Cardona D, Jia M, Zheng
R, Zhu H, Crawford JM and Liu C: The antigen for Hep Par 1 antibody
is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab
Invest. 88:78–88. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ali EZ, Khalid MK, Yunus ZM, Yakob Y, Chin
CB, Abd Latif K and Hock NL: Carbamoylphosphate synthetase 1 (CPS1)
deficiency: Clinical, biochemical, and molecular characterization
in Malaysian patients. Eur J Pediatr. 175:339–346. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leong AS, Sormunen RT, Tsui WM and Liew
CT: Hep Par 1 and selected antibodies in the immunohistological
distinction of hepatocellular carcinoma from cholangiocarcinoma,
combined tumours and metastatic carcinoma. Histopathology.
33:318–324. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chu PG, Jiang Z and Weiss LM: Hepatocyte
antigen as a marker of intestinal metaplasia. Am J Surg Pathol.
27:952–959. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ocak GA, Yildirim G and Elpek GO:
Hepatocyte antigen expression in subtypes of intestinal metaplasia
of the stomach. West Indian Med J. 61:659–664. 2012.PubMed/NCBI
|
|
6
|
Abu-Zeid RM and Farid RM: Role of
Hepatocyte Paraffin 1 antigen in the course of colorectal
carcinogenesis. Int J Physiol Pathophysiol Pharmacol. 5:177–183.
2013.PubMed/NCBI
|
|
7
|
Cardona DM, Zhang X and Liu C: Loss of
carbamoyl phosphate synthetase I in small-intestinal
adenocarcinoma. Am J Clin Pathol. 132:877–882. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nemolato S, Ravarino A, Fanni D, Coni P,
Di Felice E, Senes G and Faa G: Hepatocyte paraffin 1
immunoreactivity in early colon carcinogenesis. Gastroenterology
Res. 2:277–281. 2009.PubMed/NCBI
|
|
9
|
Srivastava S, Kern F, Sharma N, McKeon F,
Xian W, Yeoh KG, Ho KY and The M: FABP1 and Hepar expression levels
in Barrett's esophagus and associated neoplasia in an Asian
population. Dig Liver Dis. 49:1104–1109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kinoshita M and Miyata M: Underexpression
of mRNA in human hepatocellular carcinoma focusing on eight loci.
Hepatology. 36:433–438. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee YY, Li CF, Lin CY, Lee SW, Sheu MJ,
Lin LC, Chen TJ, Wu TF and Hsing CH: Overexpression of CPS1 is an
independent negative prognosticator in rectal cancers receiving
concurrent chemoradiotherapy. Tumour Biol. 35:11097–11105. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Celiktas M, Tanaka I, Tripathi SC,
Fahrmann JF, Aguilar-Bonavides C, Villalobos P, Delgado O, Dhillon
D, Dennison JB, Ostrin EJ, et al: Role of CPS1 in cell growth,
metabolism and prognosis in LKB1-inactivated lung adenocarcinoma. J
Natl Cancer Inst. 109:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu G, Zhao Z, Yan Y, Zhou Y, Wei J, Chen
X, Lin W, Ou C, Li J, Wang X, et al: CPS1 expression and its
prognostic significance in lung adenocarcinoma. Ann Transl Med.
8:3412020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim J, Hu Z, Cai L, Li K, Choi E, Faubert
B, Bezwada D, Rodriguez-Canales J, Villalobos P, Lin YF, et al:
CPS1 maintains pyrimidine pools and DNA synthesis in
KRAS/LKB1-mutant lung cancer cells. Nature. 546:168–172. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li L, Mao Y, Zhao L, Li L, Wu J, Zhao M,
Du W, Yu L and Jiang P: p53 regulation of ammonia metabolism
through urea cycle controls polyamine biosynthesis. Nature.
567:253–256. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen P, Guo H, Wu X, Li J, Duan X, Ba Q
and Wang H: Epigenetic silencing of microRNA-204 by Helicobacter
pylori augments the NF-κB signaling pathway in gastric cancer
development and progression. Carcinogenesis. 41:430–441. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Szasz AM, Lanczky A, Nagy A, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
R Core Team, . R: A language and
environment for statistical computing. R Foundation for Statistical
Computing; Vienna, Austria: 2014
|
|
19
|
Modhukur V, Iljasenko T, Metsalu T, Lokk
K, Laisk-Podar T and Vilo J: MethSurv: A web tool to perform
multivariable survival analysis using DNA methylation data.
Epigenomics. 10:277–288. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan T, Ni Z, Han C, Min Y, Sun N, Liu C,
Shi M, Lu W, Wang N, Du F, et al: SOX2 interferes with the function
of CDX2 in bile acid-induced gastric intestinal metaplasia. Cancer
Cell Int. 19:242019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Camilo V, Garrido M, Valente P, Ricardo S,
Amaral AL, Barros R, Chaves P, Carneiro F, David L and Almeida R:
Differentiation reprogramming in gastric intestinal metaplasia and
dysplasia: Role of SOX2 and CDX2. Histopathology. 66:343–350. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mutoh H, Hakamata Y, Sato K, Eda A, Yanaka
I, Honda S, Osawa H, Kaneko Y and Sugano K: Conversion of gastric
mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice.
Biochem Biophys Res Commun. 294:470–479. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi XY, Bhagwandeen B and Leong AS: CDX2
and villin are useful markers of intestinal metaplasia in the
diagnosis of Barrett esophagus. Am J Clin Pathol. 129:571–577.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ryall J, Nguyen M, Bendayan M and Shore
GC: Expression of nuclear genes encoding the urea cycle enzymes,
carbamoyl-phosphate synthetase I and ornithine carbamoyl
transferase, in rat liver and intestinal mucosa. Eur J Biochem.
152:287–292. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Qin J, Wang S, Zhang W, Duan J,
Zhang J, Wang X, Yan F, Chang M, Liu X, et al: Conversion of Human
gastric epithelial cells to multipotent endodermal progenitors
using defined small molecules. Cell Stem Cell. 19:449–461. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim Y, Kang K, Lee SB, Seo D, Yoon S, Kim
SJ, Jang K, Jung YK, Lee KG, Factor VM, et al: Small
molecule-mediated reprogramming of human hepatocytes into bipotent
progenitor cells. J Hepatol. 70:97–107. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Watt AJ, Garrison WD and Duncan SA: HNF4:
A central regulator of hepatocyte differentiation and function.
Hepatology. 37:1249–1253. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Colleypriest BJ, Burke ZD, Griffiths LP,
Chen Y, Yu WY, Jover R, Bock M, Biddlestone L, Quinlan JM, Ward SG,
et al: Hnf4α is a key gene that can generate columnar metaplasia in
oesophageal epithelium. Differentiation. 93:39–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Montenegro-Miranda PS, van der Meer JHM,
Jones C, Meisner S, Vermeulen JLM, Koster J, Wildenberg ME,
Heijmans J, Boudreau F, Ribeiro A, et al: A novel organoid model of
damage and repair identifies HNF4α as a critical regulator of
intestinal epithelial regeneration. Cell Mol Gastroenterol Hepatol.
10:209–223. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jin Y, Liang ZY, Zhou WX and Zhou L:
Combination with CK19 Might increase the prognostic power of hep
par 1 in hepatocellular carcinoma after curative resection. J
Invest Surg. 31:412–419. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan Z, Li J, Dong B and Huang X:
Expression of Cdx2 and hepatocyte antigen in gastric carcinoma:
Correlation with histologic type and implications for prognosis.
Clin Cancer Res. 11:6162–6170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maitra A, Murakata LA and Albores-Saavedra
J: Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid
adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol.
115:689–694. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Z, Tang N, Wang X and Chen Y: The
activity of the carbamoyl phosphate synthase 1 promoter in human
liver-derived cells is dependent on hepatocyte nuclear factor
3-beta. J Cell Mol Med. 21:2036–2045. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takiguchi M and Mori M: Transcriptional
regulation of genes for ornithine cycle enzymes. Biochem J.
312:649–659. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guei TR, Liu MC, Yang CP and Su TS:
Identification of a liver-specific cAMP response element in the
human argininosuccinate synthetase gene. Biochem Biophys Res
Commun. 377:257–261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu H, Dong H, Robertson K and Liu C: DNA
methylation suppresses expression of the urea cycle enzyme
carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular
carcinoma. Am J Pathol. 178:652–661. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cancer Genome Atlas Research Network.
Electronic address, . simplewheeler@bcm.edu; Cancer
Genome Atlas Research Network: Comprehensive and integrative
genomic characterization of hepatocellular carcinoma. Cell.
169:1327–1341 e23. 2017. View Article : Google Scholar : PubMed/NCBI
|
